US FDA 510(k) Submission
for medical devices and IVDs

Your entry point to the US market

of medical devices.

Accessing the U.S. market requires full compliance with the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the relevant 21 CFR Parts applicable to medical devices and in vitro diagnostic devices. For many Class II devices and selected Class I or Class III devices, this includes preparing a FDA 510(k) submission to demonstrate substantial equivalence to a legally marketed predicate device.

ALTRION supports manufacturers throughout the FDA 510(k) submission for medical devices, from regulatory classification and quality system setup to FDA submission, Device Listing and post-market compliance. The objective is to help companies define a clear regulatory pathway, prepare complete documentation and enter the U.S. market with stronger regulatory readiness.

FDA 510(k) submission and U.S. regulatory compliance

A FDA 510(k) submission is a premarket notification required when a medical device must obtain FDA clearance before being marketed in the United States. The process is based on demonstrating that the device is substantially equivalent to a legally marketed device in terms of intended use, technological characteristics, safety and performance.

The U.S. regulatory framework includes several key requirements, including 21 CFR Part 801 for labeling and Instructions for Use, Part 807 for Establishment Registration, Device Listing and 510(k) Premarket Notification, Part 820 for Quality System Regulation, Part 830 for Unique Device Identification and GUDID submission, Part 803 for Medical Device Reporting and Part 806 for Corrections and Removals.

Regulatory strategy and classification analysis

Every FDA 510(k) submission starts with a clear regulatory strategy. ALTRION supports manufacturers in analyzing device classification, identifying the applicable requirements and defining the correct pathway for U.S. market access. This phase helps determine the submission route, product code, documentation requirements and evidence needed to support the device.

For Class I devices, unless exempt, Establishment Registration, Device Listing and a Quality Management System aligned with 21 CFR Part 820 may be required. For Class II and selected Class I or III devices, a 510(k) premarket clearance may be necessary to demonstrate substantial equivalence.

Predicate device research and substantial equivalence

Predicate device research is one of the most important steps in the 510(k) process. ALTRION helps manufacturers identify suitable legally marketed predicate devices and assess whether the new device can be compared in terms of intended use, technological characteristics and performance.

The substantial equivalence justification must be clear, coherent and supported by appropriate evidence. A weak predicate strategy can generate delays or additional FDA questions. ALTRION supports manufacturers in building a stronger comparison between the subject device and the selected predicate.

510(k) dossier preparation and eSTAR support

ALTRION provides full preparation of the 510(k) dossier, including Traditional, Special and Abbreviated 510(k) submissions where applicable. The dossier must clearly present the device, intended use, technical characteristics, labeling, performance data and substantial equivalence rationale.

ALTRION also supports eSTAR electronic submission, helping manufacturers prepare the required information in the appropriate format. A complete and well-structured electronic submission can reduce inconsistencies and improve the efficiency of the FDA review process.

Establishment Registration, Device Listing, UDI and GUDID

For devices entering the U.S. market, Establishment Registration and Device Listing may be required under 21 CFR Part 807. ALTRION assists manufacturers with registration and listing activities, helping them manage key administrative and regulatory steps connected to market access.

ALTRION also supports UDI generation and GUDID database submission under 21 CFR Part 830. These activities are important for device identification, traceability and regulatory transparency in the U.S. market.

Quality system, labeling and IFU compliance

Compliance with Quality System Regulation requirements under 21 CFR Part 820 is a key element of U.S. medical device regulation. ALTRION supports Quality System implementation and gap assessment, helping manufacturers evaluate whether their current processes are aligned with FDA expectations.

Labeling and Instructions for Use must also comply with 21 CFR Part 801 and remain consistent with the device’s intended use, regulatory classification and supporting documentation. ALTRION reviews labeling and IFU content to help manufacturers reduce inconsistencies and align user-facing information with the FDA submission strategy.

Medical Device Reporting and corrective action procedures

Post-market compliance is a fundamental part of U.S. medical device regulation. ALTRION supports manufacturers with Medical Device Reporting procedures under 21 CFR Part 803 and corrective action procedures related to Corrections and Removals under 21 CFR Part 806.

These activities help manufacturers monitor device performance, manage reportable events and respond appropriately when corrective actions are required after market entry.

FDA communication and U.S. Agent representation

Communication with the FDA can be decisive during the submission process. ALTRION supports communication management with the FDA and helps manufacturers prepare responses to deficiencies or clarification requests. Clear and technically grounded responses can help address reviewer questions more effectively.

ALTRION also provides U.S. Agent representation for foreign manufacturers, supporting regulatory communication and responsibilities connected to U.S. market access, registration, listing, 510(k) submission activities and post-market compliance.

FAQ about FDA 510(k) submission for medical devices

A FDA 510(k) submission is a premarket notification used to demonstrate that a medical device is substantially equivalent to a legally marketed device. When required, it must be submitted before the device can be marketed in the United States.

Class II devices and selected Class I or III devices may require a 510(k) premarket clearance. The requirement depends on device classification, product code, intended use and exemption status.

Substantial equivalence means that the new device can be compared to a legally marketed predicate device in terms of intended use, technological characteristics, safety and performance.

A 510(k) dossier typically includes device description, intended use, predicate comparison, substantial equivalence justification, labeling, performance information and supporting documentation for FDA review.

Foreign manufacturers may need a U.S. Agent to support communication and regulatory activities with the FDA. ALTRION provides U.S. Agent representation for manufacturers entering the U.S. market.

Why choose ALTRION

ALTRION supports manufacturers with extensive experience in FDA submissions and reviewer interactions, helping companies manage the 510(k) pathway with greater clarity and regulatory control. Its expertise in QSR alignment and risk-based classification allows manufacturers to define the right strategy from the beginning, while optimized documentation quality can support a faster and more efficient time-to-market. ALTRION also provides end-to-end compliance support, from registration and submission activities to post-market vigilance.

Deliverables

At the end of the FDA 510(k) submission process, ALTRION provides manufacturers with the documentation and regulatory outputs needed to support U.S. market access and ongoing compliance.

  • Complete 510(k) submission package or Device Listing record.
  • FDA acknowledgment, clearance letter or registration confirmation.
  • Regulatory summary, QSR compliance checklist and GUDID entry confirmation.

Are you interested in the US market?

Fill out the form with your request.

We will contact you as soon as possible.

Contact form

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.